Shane Kovacs, Chief Operating and Financial Officer of Olema Pharmaceuticals ($OLMA), sold nearly $3 million in company shares through two open market transactions over the past year. His most recent sale occurred on January 15, 2026. These sales rank him 2,740th among 11,678 insiders by total value sold, below the average of $8.6 million per seller and 6 transactions. Kovacs made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 100000 | $28.73 | 139,727.0000 | 85,732,221 | 41.71% | 0.12% |
| Jan. 13, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 3822 | $28.01 | 239,727.0000 | 85,732,221 | 1.57% | 0.00% |
| Dec. 8, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | G | Common Stock | 75000 | $0.00 | 243,549.0000 | 85,732,221 | 23.54% | 0.09% |
| Nov. 26, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | G | Common Stock | 225000 | $0.00 | 318,549.0000 | 85,732,221 | 41.39% | 0.26% |
| Feb. 28, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 58,743,522 | 9999.99% | 0.54% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 17950 | $8.66 | 543,955.0000 | 57,262,803 | 3.19% | 0.03% |
| Dec. 11, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 406 | $9.39 | 543,549.0000 | 57,262,803 | 0.07% | 0.00% |
| Dec. 9, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | A | Common Stock | 68250 | $0.00 | 578,708.0000 | 57,262,803 | 13.37% | 0.12% |
| Dec. 10, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 16803 | $9.37 | 561,905.0000 | 57,262,803 | 2.90% | 0.03% |
| Nov. 15, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | Ch. Operating & Financial Off. | M | Common Stock | 25000 | $7.02 | 510,458.0000 | 57,262,803 | 5.15% | 0.04% |
| Nov. 15, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | Ch. Operating & Financial Off. | M | Stock Option (Right to Buy) | 25000 | $0.00 | 162,000.0000 | 57,262,803 | 13.37% | 0.04% |
| Feb. 1, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | A | Stock Option (Right to Buy) | 304500 | $0.00 | 304,500.0000 | 45,247,098 | 9999.99% | 0.67% |
| Jan. 12, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | M | Stock Option (Right to Buy) | 50000 | $0.00 | 187,000.0000 | 45,247,098 | 21.10% | 0.11% |
| Jan. 12, 2024 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | M | Common Stock | 50000 | $7.02 | 484,987.0000 | 45,247,098 | 11.49% | 0.11% |
| Dec. 12, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | M | Stock Option (Right to Buy) | 10000 | $0.00 | 237,000.0000 | 0 | 4.05% | 0.00% |
| Dec. 12, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | M | Common Stock | 10000 | $7.02 | 434,987.0000 | 0 | 2.35% | 0.00% |
| Nov. 20, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | A | Common Stock | 36750 | $0.00 | 443,729.0000 | 0 | 9.03% | 0.00% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 700 | $15.27 | 434,132.0000 | 0 | 0.16% | 0.00% |
| Nov. 21, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 8897 | $14.83 | 434,832.0000 | 0 | 2.01% | 0.00% |
| Nov. 22, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | S | Common Stock | 9145 | $13.89 | 424,987.0000 | 0 | 2.11% | 0.00% |
| April 6, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | P | Common Stock | 10000 | $0.00 | 396,197.0000 | 0 | 2.59% | 0.00% |
| Feb. 1, 2023 | Olema Pharmaceuticals, Inc. | $OLMA | Kovacs Shane William Charles | Ch. Operating & Financial Off. | A | Stock Option (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |